MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

CLX · NYSE

Clorox Company (The)

Consumer Discretionary · Specialty Chemicals

Reference price$100.32As of Jul 28, 2026
Market capitalization$12.13B
52-week range$84.70–$130.41
S&P 500 portfolio weight0.02%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$83.00-17.3% vs. reference
Average$96.15-4.2% vs. reference
High$118.00+17.6% vs. reference
0 Buy10 Hold4 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 3, 2026Jun 2026
Consensus EPS$1.648 estimates
Expected range$1.57–$1.71Low to high EPS
Jun 2026$5.52Street EPS consensus
Jun 2027$6.03Street EPS consensus
Jun 2028$6.49Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Jun 30, 2025.

MetricCurrentPrior
Revenue+0.2% YoY$7.1B$7.09B
Operating income$1.2B$0.92B
Net income$0.81B$0.28B
Operating cash flow$0.98B$0.7B
Capital expenditures($0.22B)($0.21B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

BNK Invest

Notable Tuesday Option Activity: GLW, CLX, CARR

Zacks

Reynolds Growth Drivers and Risks Investors Should Watch Now in 2026

Zacks

Earnings Preview: Clorox (CLX) Q4 Earnings Expected to Decline

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.